Forenbacher H H
Wien Med Wochenschr. 1985 Mar 15;135(5):123-6.
109 patients entered a multicentre study for treatment with Cefoperazone of respiratory, urogenital, and hepato-biliary tract infections, as well as peritonitis. The purpose of the study was to determine the efficacy, tolerance as well as the therapeutic advantages of a new agent of the group of betalactam-antibiotics which is excreted by the liver with the bile and--to a far lesser extent--by the kidneys. The mean duration of therapy was 7.2 days. The mean dosage was 2 g twice a day. Efficacy and tolerance of Cefoperazone were excellent.
109名患者进入一项多中心研究，接受头孢哌酮治疗呼吸道、泌尿生殖系统、肝胆系统感染以及腹膜炎。该研究的目的是确定一种新型β-内酰胺类抗生素的疗效、耐受性以及治疗优势，这种抗生素主要通过肝脏随胆汁排泄，经肾脏排泄的量极少。平均治疗时长为7.2天。平均剂量为每日两次，每次2克。头孢哌酮的疗效和耐受性极佳。
